Continuous Glucose Monitoring Systems Market by Components (Sensors, Transmitters & Receivers, and Integrated Insulin Pumps), Demographics (Child Population (<=14years), and Adult Population (>14years), and End User (Clinics and Diagnostics Centers, ICUs, and Home Healthcare) - Global Opportunity Analysis and Industry Forecast, 2020-2030

Continuous Glucose Monitoring Systems Market

Industry:  Life Sciences & Healthcare | Publish Date: Dec 2020 | No of Pages:  309 | No. Tables:  171 | No. Figures:  141

Market Definition:

The Global Continuous Glucose Monitoring Systems Market size was valued at USD 1.76 billion in 2019 and is predicted to reach USD 13.81 billion by 2030 with a CAGR of 20.6% from 2020-2030.

Continuous Glucose Monitoring (CGM) system is one of the most advanced technologies used for monitoring the glucose levels of people suffering from diabetes. This system consists of three parts including a transmitter, a glucose sensor, and a small receiver that displays the glucose information. The CGM system takes glucose measurements at regular intervals and translates them into dynamic data to show glucose direction and rate of change. This helps the user to understand the impact of meals, illness and exercise on glucose level, and hence decreases the chances of blood glucose related medical emergencies.

Market Dynamics and Trends:

Continuous Glucose Monitoring Systems market is primarily driven by surge in geriatric population and patients suffering from diabetes. According to the International Diabetes Federation in 2019, approximately 463 million adults (20-79 years) were living with diabetes, and the number is expected to reach 700 million by 2045. The rising awareness regarding diabetes worldwide and the rapid acceptance of innovative technology such as continuous glucose monitoring and artificial pancreas are expected to boost the continuous glucose monitoring systems market growth.

However, lack of adequate reimbursement for such devices is acting as the key barrier to the wide scale adoption of these devices. On the other hand, high growth prospects in the untapped markets are expected to provide lucrative opportunities for manufacturers in the near future.

Market Segmentations and Scope of the Study:

The global Continuous Glucose Monitoring Systems market share has been analyzed based on component, demographics, end user, and region. Based on component, the market is segmented into transmitters & receivers and integrated insulin pumps; and sensors. On the basis of demographics, CGMS are categorized into child population (≤14 years) and adult population (>14 years). Based on end user, the market is classified into clinics and diagnostics centers, ICUs, and home healthcare. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis:

North America dominates the continuous glucose monitoring systems market and is anticipated to maintain this trend throughout the forecast period. This is attributed to factors such as the rising prevalence of diabetes among people and various government initiatives with regard to the reimbursement scenarios for such devices. Also, technological advancements and increasing R&D to bring down the cost and improve efficacy are some of the factors expected to propel the market growth in North America.

Competitive Landscape:

The global continuous glucose monitoring systems market is highly competitive and consists of numerous market players. Some of the major market players are market includes Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., GlySens Incorporated, Johnson & Johnson, Medtronic plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche Ltd. There have been various developments taking place in the market that further enhance the growth of Continuous Glucose Monitoring Systems market on a large scale.

KEY BENEFITS:

  • The continuous glucose monitoring systems market report provides quantitative market analysis and estimations through 2020-2030 that assists to determine the predominant market opportunities to exploit.

  • The study comprises a deep drive analysis of continuous glucose monitoring systems Market Trends including current and upcoming trends for interpreting the prevalent investment pockets in the market.

  • The report gives intricate information related to key drivers, restraints, opportunities and their impact on continuous glucose monitoring systems market.

  • The report consolidates a competitive analysis of the market players along with their market share in global continuous glucose monitoring systems market.

  • The study elaborates SWOT analysis and Porters Five Force model for the continuous glucose monitoring systems market.

  • Value chain analysis in the market study provides a clear picture of the stakeholders’ roles in the global continuous glucose monitoring systems market.

KEY MARKET SEGMENTS:                                                 

By Component

  • Sensors 

  • Transmitters & Receivers 

  • Integrated Insulin Pumps

By Demographics

  • Child Population (≤14 years)

  • Adult Population (>14 years)

By End User

  • Diagnostics/Clinics

  • ICUs

  • Home Healthcare

By Region

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Spain

    • Italy

    • Netherlands

    • Norway

    • Sweden

    • Denmark

    • Finland

    • Rest of Europe

  • Asia-Pacific

    • China

    • India

    • Australia

    • Japan

    • South Korea

    • Rest of Asia-Pacific

  • Rest of World

    • Brazil 

    • Venezuela

    • Saudi Arabia 

    • South Africa

    • Argentina

    • Remaining Countries

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Analysis Period

2019–2030

Base Year Considered

2020

Forecast Period

2020–2030

Market Size Estimation

Billion (USD)

Market Segmentation

By Component (Sensors, Transmitters & Receivers, Integrated Insulin Pumps) By Demographics (Child Population (≤14 years), Adult Population (>14 years) By End User (Diagnostics/Clinics, ICUs, Home Healthcare)

Geographical Segmentation

North America (U.S., Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Netherlands, Norway, Sweden, Denmark, Finland, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC) Rest of World (Brazil, Venezuela, Saudi Arabia, South Africa, Argentina, Remaining Countries)

Companies Profiled

Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., GlySens Incorporated, Johnson & Johnson, Medtronic plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche Ltd.

column chart pie chart

1.... INTRODUCTION

1.1.           REPORT DESCRIPTION

1.2.           Research Methodology

1.2.1             Secondary Research

1.2.2             Data Analysis Framework

1.2.3             Market size estimation

1.2.4             Forecasting

1.2.5             Primary Research and Data Validation

2.... MARKET SNAPSHOT, 2019-2030 Million USD

2.1.           MARKET SNAPSHOT

3.... PORTER’S FIVE FORCE MODEL ANALYSIS

4.... MARKET DYNAMICS

4.1.           GROWTH DRIVERS

4.1.1             DRIVER 1

4.1.2             DRIVER 2

4.1.3             DRIVER 3

4.1.4             DRIVER 4

4.2.           CHALLENGES

4.2.1             CHALLENGE 1

4.2.2             CHALLENGE 2

4.3.           OPPORTUNITIES

4.3.1             OPPORTUNITY 1

4.3.2             OPPORTUNITY 2

5.... Global  Continuous Glucose Monitoring Systems  Market, By Components

5.1.           Overview

5.2.           Sensors

5.2.1             Sensors Market, By Region

5.2.1.1        North America Sensors Market, By Country

5.2.1.2        Europe Sensors Market, By Country

5.2.1.3        Asia-Pacific Sensors Market, By Country

5.2.1.4        Rest of World Sensors Market, By Country

5.3.           Transmitters & Receivers

5.3.1             Transmitters & Receivers Market, By Region

5.3.1.1        North America Transmitters & Receivers Market, By Country

5.3.1.2        Europe Transmitters & Receivers Market, By Country

5.3.1.3        Asia-Pacific Transmitters & Receivers Market, By Country

5.3.1.4        Rest of World Transmitters & Receivers Market, By Country

5.4.           Integrated Insulin Pumps

5.4.1             Integrated Insulin Pumps Market, By Region

5.4.1.1        North America Integrated Insulin Pumps Market, By Country

5.4.1.2        Europe Integrated Insulin Pumps Market, By Country

5.4.1.3        Asia-Pacific Integrated Insulin Pumps Market, By Country

5.4.1.4        Rest of World Integrated Insulin Pumps Market, By Country

6.... Global  Continuous Glucose Monitoring Systems  Market, By Demographics

6.1.           Overview

6.2.           Adult Population (>14 years)

6.2.1             Adult Population (>14 years) Market, By Region

6.2.1.1        North America Adult Population (>14 years) Market, By Country

6.2.1.2        Europe Adult Population (>14 years) Market, By Country

6.2.1.3        Asia-Pacific Adult Population (>14 years) Market, By Country

6.2.1.4        Rest of World Adult Population (>14 years) Market, By Country

6.3.           Children Population (≤14 years)

6.3.1             Children Population (≤14 years) Market, By Region

6.3.1.1        North America Children Population (≤14 years) Market, By Country

6.3.1.2        Europe Children Population (≤14 years) Market, By Country

6.3.1.3        Asia-Pacific Children Population (≤14 years) Market, By Country

6.3.1.4        Rest of World Children Population (≤14 years) Market, By Country

7.... Global  Continuous Glucose Monitoring Systems  Market, By End User

7.1.           Overview

7.2.           Diagnostic Centers/Clinics

7.2.1             Diagnostic Centers/Clinics Market, By Region

7.2.1.1        North America Diagnostic Centers/Clinics Market, By Country

7.2.1.2        Europe Diagnostic Centers/Clinics Market, By Country

7.2.1.3        Asia-Pacific Diagnostic Centers/Clinics Market, By Country

7.2.1.4        Rest of World Diagnostic Centers/Clinics Market, By Country

7.3.           ICUs

7.3.1             ICUs Market, By Region

7.3.1.1        North America ICUs Market, By Country

7.3.1.2        Europe ICUs Market, By Country

7.3.1.3        Asia-Pacific ICUs Market, By Country

7.3.1.4        Rest of World ICUs Market, By Country

7.4.           Home Healthcare

7.4.1             Home Healthcare Market, By Region

7.4.1.1        North America Home Healthcare Market, By Country

7.4.1.2        Europe Home Healthcare Market, By Country

7.4.1.3        Asia-Pacific Home Healthcare Market, By Country

7.4.1.4        Rest of World Home Healthcare Market, By Country

8.... Global  Continuous Glucose Monitoring Systems  Market, By Region

8.1.           Overview

8.2.           North America

8.2.1             North America Continuous Glucose Monitoring Systems  Market, By Component

8.2.2             North America Continuous Glucose Monitoring Systems  Market, By Demographics

8.2.3             North America Continuous Glucose Monitoring Systems  Market, By End User

8.2.4             North America Continuous Glucose Monitoring Systems , Market By Country

8.2.4.1        U.S.

8.2.4.1.1        U.S. Continuous Glucose Monitoring Systems  Market, By Components

8.2.4.1.2        U.S. Continuous Glucose Monitoring Systems  Market, By Demographics

8.2.4.1.3        U.S. Continuous Glucose Monitoring Systems  Market, By End User

8.2.4.2        Canada

8.2.4.2.1        Canada Continuous Glucose Monitoring Systems  Market, By Components

8.2.4.2.2        Canada Continuous Glucose Monitoring Systems  Market, By Demographics

8.2.4.2.3        Canada Continuous Glucose Monitoring Systems  Market, By End User

8.2.4.3        Mexico

8.2.4.3.1        Mexico Continuous Glucose Monitoring Systems  Market, By Components

8.2.4.3.2        Mexico Continuous Glucose Monitoring Systems  Market, By Demographics

8.2.4.3.3        Mexico Continuous Glucose Monitoring Systems  Market, By End User

8.3.           Europe

8.3.1             Europe Continuous Glucose Monitoring Systems  Market, By Component

8.3.2             Europe Continuous Glucose Monitoring Systems  Market, By Demographics

8.3.3             Europe Continuous Glucose Monitoring Systems  Market, By End User

8.3.4             Europe Continuous Glucose Monitoring Systems , Market By Country

8.3.4.1        UK

8.3.4.1.1        UK Continuous Glucose Monitoring Systems  Market, By Components

8.3.4.1.2        UK Continuous Glucose Monitoring Systems  Market, By Demographics

8.3.4.1.3        UK Continuous Glucose Monitoring Systems  Market, By End User

8.3.4.2        Germany

8.3.4.2.1        Germany Continuous Glucose Monitoring Systems  Market, By Components

8.3.4.2.2        Germany Continuous Glucose Monitoring Systems  Market, By Demographics

8.3.4.2.3        Germany Continuous Glucose Monitoring Systems  Market, By End User

8.3.4.3        France

8.3.4.3.1        France Continuous Glucose Monitoring Systems  Market, By Components

8.3.4.3.2        France Continuous Glucose Monitoring Systems  Market, By Demographics

8.3.4.3.3        France Continuous Glucose Monitoring Systems  Market, By End User

8.3.4.4        Italy

8.3.4.4.1        Italy Continuous Glucose Monitoring Systems  Market, By Components

8.3.4.4.2        Italy Continuous Glucose Monitoring Systems  Market, By Demographics

8.3.4.4.3        Italy Continuous Glucose Monitoring Systems  Market, By End User

8.3.4.5        Spain

8.3.4.5.1        Spain Continuous Glucose Monitoring Systems  Market, By Components

8.3.4.5.2        Spain Continuous Glucose Monitoring Systems  Market, By Demographics

8.3.4.5.3        Spain Continuous Glucose Monitoring Systems  Market, By End User

8.3.4.6        Netherlands

8.3.4.6.1 Netherlands Continuous Glucose Monitoring Systems  Market, By Components

8.3.4.6.2 Netherlands Continuous Glucose Monitoring Systems  Market, By Demographics

8.3.4.6.3 Netherlands Continuous Glucose Monitoring Systems  Market, By End User

8.3.4.7        Sweden

8.3.4.7.1        Sweden Continuous Glucose Monitoring Systems  Market, By Components

8.3.4.7.2        Sweden Continuous Glucose Monitoring Systems  Market, By Demographics

8.3.4.7.3        Sweden Continuous Glucose Monitoring Systems  Market, By End User

8.3.4.8        Denmark

8.3.4.8.1        Denmark Continuous Glucose Monitoring Systems  Market, By Components

8.3.4.8.2        Denmark Continuous Glucose Monitoring Systems  Market, By Demographics

8.3.4.8.3        Denmark Continuous Glucose Monitoring Systems  Market, By End User

8.3.4.9        Finland

8.3.4.9.1        Finland Continuous Glucose Monitoring Systems  Market, By Components

8.3.4.9.2        Finland Continuous Glucose Monitoring Systems  Market, By Demographics

8.3.4.9.3        Finland Continuous Glucose Monitoring Systems  Market, By End User

8.3.4.10      Rest of Europe

8.3.4.10.1      Rest of Europe Continuous Glucose Monitoring Systems  Market, By Components

8.3.4.10.2      Rest of Europe Continuous Glucose Monitoring Systems  Market, By Demographics

8.3.4.10.3      Rest of Europe Continuous Glucose Monitoring Systems  Market, By End User

8.4.           Asia-Pacific

8.4.1             Asia-Pacific Continuous Glucose Monitoring Systems  Market, By Component

8.4.2             Asia-Pacific Continuous Glucose Monitoring Systems  Market, By Demographics

8.4.3             Asia-Pacific Continuous Glucose Monitoring Systems  Market, By End User

8.4.4             Asia-Pacific Continuous Glucose Monitoring Systems , Market By Country

8.4.4.1        India

8.4.4.1.1        India Continuous Glucose Monitoring Systems  Market, By Components

8.4.4.1.2        India Continuous Glucose Monitoring Systems  Market, By Demographics

8.4.4.1.3        India Continuous Glucose Monitoring Systems  Market, By End User

8.4.4.2        China

8.4.4.2.1        China Continuous Glucose Monitoring Systems  Market, By Components

8.4.4.2.2        China Continuous Glucose Monitoring Systems  Market, By Demographics

8.4.4.2.3        China Continuous Glucose Monitoring Systems  Market, By End User

8.4.4.3        Japan

8.4.4.3.1        Japan Continuous Glucose Monitoring Systems  Market, By Components

8.4.4.3.2        Japan Continuous Glucose Monitoring Systems  Market, By Demographics

8.4.4.3.3        Japan Continuous Glucose Monitoring Systems  Market, By End User

8.4.4.4        Australia

8.4.4.4.1        Australia Continuous Glucose Monitoring Systems  Market, By Components

8.4.4.4.2        Australia Continuous Glucose Monitoring Systems  Market, By Demographics

8.4.4.4.3        Australia Continuous Glucose Monitoring Systems  Market, By End User

8.4.4.5        South Korea

8.4.4.5.1        South Korea Continuous Glucose Monitoring Systems  Market, By Components

8.4.4.5.2        South Korea Continuous Glucose Monitoring Systems  Market, By Demographics

8.4.4.5.3        South Korea Continuous Glucose Monitoring Systems  Market, By End User

8.4.4.6        Rest of Asia-Pacific

8.4.4.6.1        Rest of Asia-Pacific Continuous Glucose Monitoring Systems  Market, By Components

8.4.4.6.2        Rest of Asia-Pacific Continuous Glucose Monitoring Systems  Market, By Demographics

8.4.4.6.3        Rest of Asia-Pacific Continuous Glucose Monitoring Systems  Market, By End User

8.5.           Rest of World

8.5.1             Rest of World Continuous Glucose Monitoring Systems  Market, By Component

8.5.2             Rest of World Continuous Glucose Monitoring Systems  Market, By Demographics

8.5.3             Rest of World Continuous Glucose Monitoring Systems  Market, By End User

8.5.4             Rest of World Continuous Glucose Monitoring Systems , Market By Country

8.5.4.1        Brazil

8.5.4.1.1        Brazil Continuous Glucose Monitoring Systems  Market, By Components

8.5.4.1.2        Brazil Continuous Glucose Monitoring Systems  Market, By Demographics

8.5.4.1.3        Brazil Continuous Glucose Monitoring Systems  Market, By End User

8.5.4.2        Saudi Arabia

8.5.4.2.1        Saudi Arabia Continuous Glucose Monitoring Systems  Market, By Components

8.5.4.2.2        Saudi Arabia Continuous Glucose Monitoring Systems  Market, By Demographics

8.5.4.2.3        Saudi Arabia Continuous Glucose Monitoring Systems  Market, By End User

8.5.4.3        South Africa

8.5.4.3.1        South Africa Continuous Glucose Monitoring Systems  Market, By Components

8.5.4.3.2        South Africa Continuous Glucose Monitoring Systems  Market, By Demographics

8.5.4.3.3        South Africa Continuous Glucose Monitoring Systems  Market, By End User

8.5.4.4        Venezuela

8.5.4.4.1        Venezuela Continuous Glucose Monitoring Systems  Market, By Components

8.5.4.4.2        Venezuela Continuous Glucose Monitoring Systems  Market, By Demographics

8.5.4.4.3        Venezuela Continuous Glucose Monitoring Systems  Market, By End User

8.5.4.5        Argentina

8.5.4.5.1        Argentina  Continuous Glucose Monitoring Systems  Market, By Components

8.5.4.5.2        Argentina  Continuous Glucose Monitoring Systems  Market, By Demographics

8.5.4.5.3        Argentina  Continuous Glucose Monitoring Systems  Market, By End User

8.5.4.6        Remaining Countries

8.5.4.6.1        Remaining Countries Continuous Glucose Monitoring Systems  Market, By Components

8.5.4.6.2        Remaining Countries Continuous Glucose Monitoring Systems  Market, By Demographics

8.5.4.6.3        Remaining Countries Continuous Glucose Monitoring Systems  Market, By End User

9.... COMPANY PROFILES

9.1.           Abbott Laboratories

9.1.1             COMPANY OVERVIEW

9.1.2             COMPANY SNAPSHOT

9.1.3             OPERATING BUSINESS SEGMENTS

9.1.4             PRODUCT PORTFOLIO

9.1.5             BUSINESS PERFORMANCE

9.1.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.2.           Menarini Diagnostics S.r.l.

9.2.1             COMPANY OVERVIEW

9.2.2             COMPANY SNAPSHOT

9.2.3             OPERATING BUSINESS SEGMENTS

9.2.4             PRODUCT PORTFOLIO

9.2.5             BUSINESS PERFORMANCE

9.2.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.3.           DexCom, Inc.

9.3.1             COMPANY OVERVIEW

9.3.2             COMPANY SNAPSHOT

9.3.3             OPERATING BUSINESS SEGMENTS

9.3.4             PRODUCT PORTFOLIO

9.3.5             BUSINESS PERFORMANCE

9.3.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.4.           Echo Therapeutics, Inc.

9.4.1             COMPANY OVERVIEW

9.4.2             COMPANY SNAPSHOT

9.4.3             OPERATING BUSINESS SEGMENTS

9.4.4             PRODUCT PORTFOLIO

9.4.5             BUSINESS PERFORMANCE

9.4.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.5.           Hoffmann-La Roche Ltd.

9.5.1             COMPANY OVERVIEW

9.5.2             COMPANY SNAPSHOT

9.5.3             OPERATING BUSINESS SEGMENTS

9.5.4             PRODUCT PORTFOLIO

9.5.5             BUSINESS PERFORMANCE

9.5.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.6.           GlySens Incorporated

9.6.1             COMPANY OVERVIEW

9.6.2             COMPANY SNAPSHOT

9.6.3             OPERATING BUSINESS SEGMENTS

9.6.4             PRODUCT PORTFOLIO

9.6.5             BUSINESS PERFORMANCE

9.6.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.7.           Insulet Corporation

9.7.1             COMPANY OVERVIEW

9.7.2             COMPANY SNAPSHOT

9.7.3             OPERATING BUSINESS SEGMENTS

9.7.4             PRODUCT PORTFOLIO

9.7.5             BUSINESS PERFORMANCE

9.7.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.8.           Johnson & Johnson

9.8.1             COMPANY OVERVIEW

9.8.2             COMPANY SNAPSHOT

9.8.3             OPERATING BUSINESS SEGMENTS

9.8.4             PRODUCT PORTFOLIO

9.8.5             BUSINESS PERFORMANCE

9.8.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.9.           Medronic PLC

9.9.1             COMPANY OVERVIEW

9.9.2             COMPANY SNAPSHOT

9.9.3             OPERATING BUSINESS SEGMENTS

9.9.4             PRODUCT PORTFOLIO

9.9.5             BUSINESS PERFORMANCE

9.9.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.10.         Senseonics Holdings, Inc.

9.10.1           COMPANY OVERVIEW

9.10.2           COMPANY SNAPSHOT

9.10.3           OPERATING BUSINESS SEGMENTS

9.10.4           PRODUCT PORTFOLIO

9.10.5           BUSINESS PERFORMANCE

9.10.6           KEY STRATEGIC MOVES AND DEVELOPMENT

LIST OF TABLES

TABLE 1.         Global  Continuous Glucose Monitoring Systems  Market Value, By Components, 2019-2030, Million USD

TABLE 2.         Sensors Market Value, By Region, 2019-2030, Million USD

TABLE 3.         North America Sensors Market Value, By Country, 2019-2030, Million USD

TABLE 4.         Europe Sensors Market Value, By Country, 2019-2030, Million USD

TABLE 5.         Asia-Pacific Sensors Market Value, By Country, 2019-2030, Million USD

TABLE 6.         Rest of World Sensors Market Value, By Country, 2019-2030, Million USD

TABLE 7.         Transmitters & Receivers Market Value, By Region, 2019-2030, Million USD

TABLE 8.         North America Transmitters & Receivers Market Value, By Country, 2019-2030, Million USD

TABLE 9.         Europe Transmitters & Receivers Market Value, By Country, 2019-2030, Million USD

TABLE 10.       Asia-Pacific Transmitters & Receivers Market Value, By Country, 2019-2030, Million USD

TABLE 11.       Rest of World Transmitters & Receivers Market Value, By Country, 2019-2030, Million USD

TABLE 12.       Integrated Insulin Pumps Market Value, By Region, 2019-2030, Million USD

TABLE 13.       North America Integrated Insulin Pumps Market Value, By Country, 2019-2030, Million USD

TABLE 14.       Europe Integrated Insulin Pumps Market Value, By Country, 2019-2030, Million USD

TABLE 15.       Asia-Pacific Integrated Insulin Pumps Market Value, By Country, 2019-2030, Million USD

TABLE 16.       Rest of World Integrated Insulin Pumps Market Value, By Country, 2019-2030, Million USD

TABLE 17.       Global  Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 18.       Adult Population (>14 years) Market Value, By Region, 2019-2030, Million USD

TABLE 19.       North America Adult Population (>14 years) Market Value, By Country, 2019-2030, Million USD

TABLE 20.       Europe Adult Population (>14 years) Market Value, By Country, 2019-2030, Million USD

TABLE 21.       Asia-Pacific Adult Population (>14 years) Market Value, By Country, 2019-2030, Million USD

TABLE 22.       Rest of World Adult Population (>14 years) Market Value, By Country, 2019-2030, Million USD

TABLE 23.       Children Population (≤14 years) Market Value, By Region, 2019-2030, Million USD

TABLE 24.       North America Children Population (≤14 years) Market Value, By Country, 2019-2030, Million USD

TABLE 25.       Europe Children Population (≤14 years) Market Value, By Country, 2019-2030, Million USD

TABLE 26.       Asia-Pacific Children Population (≤14 years) Market Value, By Country, 2019-2030, Million USD

TABLE 27.       Rest of World Children Population (≤14 years) Market Value, By Country, 2019-2030, Million USD

TABLE 28.       Global  Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 29.       Diagnostic Centers/Clinics Market Value, By Region, 2019-2030, Million USD

TABLE 30.       North America Diagnostic Centers/Clinics Market Value, By Country, 2019-2030, Million USD

TABLE 31.       Europe Diagnostic Centers/Clinics Market Value, By Country, 2019-2030, Million USD

TABLE 32.       Asia-Pacific Diagnostic Centers/Clinics Market Value, By Country, 2019-2030, Million USD

TABLE 33.       Rest of World Diagnostic Centers/Clinics Market Value, By Country, 2019-2030, Million USD

TABLE 34.       ICUs Market Value, By Region, 2019-2030, Million USD

TABLE 35.       North America ICUs Market Value, By Country, 2019-2030, Million USD

TABLE 36.       Europe ICUs Market Value, By Country, 2019-2030, Million USD

TABLE 37.       Asia-Pacific ICUs Market Value, By Country, 2019-2030, Million USD

TABLE 38.       Rest of World ICUs Market Value, By Country, 2019-2030, Million USD

TABLE 39.       Home Healthcare Market Value, By Region, 2019-2030, Million USD

TABLE 40.       North America Home Healthcare Market Value, By Country, 2019-2030, Million USD

TABLE 41.       Europe Home Healthcare Market Value, By Country, 2019-2030, Million USD

TABLE 42.       Asia-Pacific Home Healthcare Market Value, By Country, 2019-2030, Million USD

TABLE 43.       Rest of World Home Healthcare Market Value, By Country, 2019-2030, Million USD

TABLE 44.       Global  Continuous Glucose Monitoring Systems  Market Value, By Region, 2019-2030, Million USD

TABLE 45.       North America Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 46.       North America Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 47.       North America Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 48.       U.S. Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 49.       U.S. Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 50.       U.S. Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 51.       Canada Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 52.       Canada Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 53.       Canada Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 54.       Mexico Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 55.       Mexico Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 56.       Mexico Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 57.       Europe Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 58.       Europe Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 59.       Europe Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 60.       UK Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 61.       UK Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 62.       UK Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 63.       Germany Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 64.       Germany Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 65.       Germany Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 66.       France Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 67.       France Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 68.       France Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 69.       Italy Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 70.       Italy Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 71.       Italy Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 72.       Spain Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 73.       Spain Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 74.       Spain Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 75.       Netherlands Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 76.       Netherlands Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 77.       Netherlands Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 78.       Sweden Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 79.       Sweden Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 80.       Sweden Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 81.       Denmark Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 82.       Denmark Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 83.       Denmark Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 84.       Finland Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 85.       Finland Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 86.       Finland Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 87.       Rest of Europe Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 88.       Rest of Europe Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 89.       Rest of Europe Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 90.       Asia-Pacific Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 91.       Asia-Pacific Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 92.       Asia-Pacific Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 93.       India Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 94.       India Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 95.       India Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 96.       China Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 97.       China Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 98.       China Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 99.       Japan Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 100.    Japan Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 101.    Japan Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 102.    Australia Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 103.    Australia Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 104.    Australia Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 105.    South Korea Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 106.    South Korea Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 107.    South Korea Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 108.    Rest of Asia-Pacific Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 109.    Rest of Asia-Pacific Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 110.    Rest of Asia-Pacific Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 111.    Rest of World Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 112.    Rest of World Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 113.    Rest of World Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 114.    Brazil Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 115.    Brazil Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 116.    Brazil Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 117.    Saudi Arabia Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 118.    Saudi Arabia Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 119.    Saudi Arabia Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 120.    South Africa Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 121.    South Africa Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 122.    South Africa Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 123.    Venezuela Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 124.    Venezuela Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 125.    Venezuela Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 126.    Argentina  Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 127.    Argentina  Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 128.    Argentina  Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 129.    Remaining Countries Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

TABLE 130.    Remaining Countries Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

TABLE 131.    Remaining Countries Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

TABLE 132.    Abbott Laboratories: COMPANY SNAPSHOT

TABLE 133.    Abbott Laboratories: OPERATING SEGMENTS

TABLE 134.    Abbott Laboratories: PRODUCT PORTFOLIO

TABLE 135.    Abbott Laboratories: KEY STRATERGY

TABLE 136.    Menarini Diagnostics S.r.l.: COMPANY SNAPSHOT

TABLE 137.    Menarini Diagnostics S.r.l.: OPERATING SEGMENTS

TABLE 138.    Menarini Diagnostics S.r.l.: PRODUCT PORTFOLIO

TABLE 139.    Menarini Diagnostics S.r.l.: KEY STRATERGY

TABLE 140.    DexCom, Inc.: COMPANY SNAPSHOT

TABLE 141.    DexCom, Inc.: OPERATING SEGMENTS

TABLE 142.    DexCom, Inc.: PRODUCT PORTFOLIO

TABLE 143.    DexCom, Inc.: KEY STRATERGY

TABLE 144.    Echo Therapeutics, Inc.: COMPANY SNAPSHOT

TABLE 145.    Echo Therapeutics, Inc.: OPERATING SEGMENTS

TABLE 146.    Echo Therapeutics, Inc.: PRODUCT PORTFOLIO

TABLE 147.    Echo Therapeutics, Inc.: KEY STRATERGY

TABLE 148.    Hoffmann-La Roche Ltd.: COMPANY SNAPSHOT

TABLE 149.    Hoffmann-La Roche Ltd.: OPERATING SEGMENTS

TABLE 150.    Hoffmann-La Roche Ltd.: PRODUCT PORTFOLIO

TABLE 151.    Hoffmann-La Roche Ltd.: KEY STRATERGY

TABLE 152.    GlySens Incorporated: COMPANY SNAPSHOT

TABLE 153.    GlySens Incorporated: OPERATING SEGMENTS

TABLE 154.    GlySens Incorporated: PRODUCT PORTFOLIO

TABLE 155.    GlySens Incorporated: KEY STRATERGY

TABLE 156.    Insulet Corporation: COMPANY SNAPSHOT

TABLE 157.    Insulet Corporation: OPERATING SEGMENTS

TABLE 158.    Insulet Corporation: PRODUCT PORTFOLIO

TABLE 159.    Insulet Corporation: KEY STRATERGY

TABLE 160.    Johnson & Johnson: COMPANY SNAPSHOT

TABLE 161.    Johnson & Johnson: OPERATING SEGMENTS

TABLE 162.    Johnson & Johnson: PRODUCT PORTFOLIO

TABLE 163.    Johnson & Johnson: KEY STRATERGY

TABLE 164.    Medronic PLC: COMPANY SNAPSHOT

TABLE 165.    Medronic PLC: OPERATING SEGMENTS

TABLE 166.    Medronic PLC: PRODUCT PORTFOLIO

TABLE 167.    Medronic PLC: KEY STRATERGY

TABLE 168.    Senseonics Holdings, Inc.: COMPANY SNAPSHOT

TABLE 169.    Senseonics Holdings, Inc.: OPERATING SEGMENTS

TABLE 170.    Senseonics Holdings, Inc.: PRODUCT PORTFOLIO

TABLE 171.    Senseonics Holdings, Inc.: KEY STRATERGY

 

 

 

LIST OF FIGURES

FIGURE 1.       Global  Continuous Glucose Monitoring Systems  Market Value, By Components, 2019-2030, Million USD

FIGURE 2.       Sensors Market Value, By Region, 2019-2030, Million USD

FIGURE 3.       North America Sensors Market Value, By Country, 2019-2030, Million USD

FIGURE 4.       Europe Sensors Market Value, By Country, 2019-2030, Million USD

FIGURE 5.       Asia-Pacific Sensors Market Value, By Country, 2019-2030, Million USD

FIGURE 6.       Rest of World Sensors Market Value, By Country, 2019-2030, Million USD

FIGURE 7.       Transmitters & Receivers Market Value, By Region, 2019-2030, Million USD

FIGURE 8.       North America Transmitters & Receivers Market Value, By Country, 2019-2030, Million USD

FIGURE 9.       Europe Transmitters & Receivers Market Value, By Country, 2019-2030, Million USD

FIGURE 10.     Asia-Pacific Transmitters & Receivers Market Value, By Country, 2019-2030, Million USD

FIGURE 11.     Rest of World Transmitters & Receivers Market Value, By Country, 2019-2030, Million USD

FIGURE 12.     Integrated Insulin Pumps Market Value, By Region, 2019-2030, Million USD

FIGURE 13.     North America Integrated Insulin Pumps Market Value, By Country, 2019-2030, Million USD

FIGURE 14.     Europe Integrated Insulin Pumps Market Value, By Country, 2019-2030, Million USD

FIGURE 15.     Asia-Pacific Integrated Insulin Pumps Market Value, By Country, 2019-2030, Million USD

FIGURE 16.     Rest of World Integrated Insulin Pumps Market Value, By Country, 2019-2030, Million USD

FIGURE 17.     Global  Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 18.     Adult Population (>14 years) Market Value, By Region, 2019-2030, Million USD

FIGURE 19.     North America Adult Population (>14 years) Market Value, By Country, 2019-2030, Million USD

FIGURE 20.     Europe Adult Population (>14 years) Market Value, By Country, 2019-2030, Million USD

FIGURE 21.     Asia-Pacific Adult Population (>14 years) Market Value, By Country, 2019-2030, Million USD

FIGURE 22.     Rest of World Adult Population (>14 years) Market Value, By Country, 2019-2030, Million USD

FIGURE 23.     Children Population (≤14 years) Market Value, By Region, 2019-2030, Million USD

FIGURE 24.     North America Children Population (≤14 years) Market Value, By Country, 2019-2030, Million USD

FIGURE 25.     Europe Children Population (≤14 years) Market Value, By Country, 2019-2030, Million USD

FIGURE 26.     Asia-Pacific Children Population (≤14 years) Market Value, By Country, 2019-2030, Million USD

FIGURE 27.     Rest of World Children Population (≤14 years) Market Value, By Country, 2019-2030, Million USD

FIGURE 28.     Global  Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 29.     Diagnostic Centers/Clinics Market Value, By Region, 2019-2030, Million USD

FIGURE 30.     North America Diagnostic Centers/Clinics Market Value, By Country, 2019-2030, Million USD

FIGURE 31.     Europe Diagnostic Centers/Clinics Market Value, By Country, 2019-2030, Million USD

FIGURE 32.     Asia-Pacific Diagnostic Centers/Clinics Market Value, By Country, 2019-2030, Million USD

FIGURE 33.     Rest of World Diagnostic Centers/Clinics Market Value, By Country, 2019-2030, Million USD

FIGURE 34.     ICUs Market Value, By Region, 2019-2030, Million USD

FIGURE 35.     North America ICUs Market Value, By Country, 2019-2030, Million USD

FIGURE 36.     Europe ICUs Market Value, By Country, 2019-2030, Million USD

FIGURE 37.     Asia-Pacific ICUs Market Value, By Country, 2019-2030, Million USD

FIGURE 38.     Rest of World ICUs Market Value, By Country, 2019-2030, Million USD

FIGURE 39.     Home Healthcare Market Value, By Region, 2019-2030, Million USD

FIGURE 40.     North America Home Healthcare Market Value, By Country, 2019-2030, Million USD

FIGURE 41.     Europe Home Healthcare Market Value, By Country, 2019-2030, Million USD

FIGURE 42.     Asia-Pacific Home Healthcare Market Value, By Country, 2019-2030, Million USD

FIGURE 43.     Rest of World Home Healthcare Market Value, By Country, 2019-2030, Million USD

FIGURE 44.     Global  Continuous Glucose Monitoring Systems  Market Value, By Region, 2019-2030, Million USD

FIGURE 45.     North America Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 46.     North America Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 47.     North America Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 48.     U.S. Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 49.     U.S. Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 50.     U.S. Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 51.     Canada Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 52.     Canada Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 53.     Canada Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 54.     Mexico Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 55.     Mexico Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 56.     Mexico Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 57.     Europe Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 58.     Europe Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 59.     Europe Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 60.     UK Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 61.     UK Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 62.     UK Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 63.     Germany Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 64.     Germany Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 65.     Germany Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 66.     France Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 67.     France Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 68.     France Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 69.     Italy Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 70.     Italy Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 71.     Italy Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 72.     Spain Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 73.     Spain Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 74.     Spain Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 75.     Netherlands Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 76.     Netherlands Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 77.     Netherlands Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 78.     Sweden Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 79.     Sweden Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 80.     Sweden Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 81.     Denmark Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 82.     Denmark Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 83.     Denmark Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 84.     Finland Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 85.     Finland Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 86.     Finland Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 87.     Rest of Europe Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 88.     Rest of Europe Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 89.     Rest of Europe Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 90.     Asia-Pacific Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 91.     Asia-Pacific Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 92.     Asia-Pacific Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 93.     India Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 94.     India Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 95.     India Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 96.     China Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 97.     China Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 98.     China Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 99.     Japan Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 100.  Japan Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 101.  Japan Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 102.  Australia Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 103.  Australia Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 104.  Australia Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 105.  South Korea Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 106.  South Korea Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 107.  South Korea Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 108.  Rest of Asia-Pacific Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 109.  Rest of Asia-Pacific Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 110.  Rest of Asia-Pacific Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 111.  Rest of World Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 112.  Rest of World Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 113.  Rest of World Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 114.  Brazil Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 115.  Brazil Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 116.  Brazil Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 117.  Saudi Arabia Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 118.  Saudi Arabia Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 119.  Saudi Arabia Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 120.  South Africa Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 121.  South Africa Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 122.  South Africa Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 123.  Venezuela Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 124.  Venezuela Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 125.  Venezuela Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 126.  Argentina  Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 127.  Argentina  Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 128.  Argentina  Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 129.  Remaining Countries Continuous Glucose Monitoring Systems  Market Value, By Component, 2019-2030, Million USD

FIGURE 130.  Remaining Countries Continuous Glucose Monitoring Systems  Market Value, By Demographics, 2019-2030, Million USD

FIGURE 131.  Remaining Countries Continuous Glucose Monitoring Systems  Market Value, By End User, 2019-2030, Million USD

FIGURE 132.  Abbott Laboratories: NET SALES,2017-2019

FIGURE 133.  Menarini Diagnostics S.r.l.: NET SALES,2017-2019

FIGURE 134.  DexCom, Inc.: NET SALES,2017-2019

FIGURE 135.  Echo Therapeutics, Inc.: NET SALES,2017-2019

FIGURE 136.  Hoffmann-La Roche Ltd.: NET SALES,2017-2019

FIGURE 137.  GlySens Incorporated: NET SALES,2017-2019

FIGURE 138.  Insulet Corporation: NET SALES,2017-2019

FIGURE 139.  Johnson & Johnson: NET SALES,2017-2019

FIGURE 140.  Medronic PLC: NET SALES,2017-2019

FIGURE 141.  Senseonics Holdings, Inc.: NET SALES,2017-2019

KEY PLAYERS:

  • Abbott Laboratories
  • Dexcom, Inc.
  • A. Menarini Diagnostics
  • Echo Therapeutics, Inc.
  • GlySens Incorporated
  • Johnson & Johnson
  • Medtronic plc
  • Senseonics Holdings, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation

Frequently Asked Questions
What will be the worth of global Continuous Glucose Monitoring Systems Market by the end of 2030?

According to the report published by Next Move Strategy Consulting, the Continuous Glucose Monitoring Systems Market business is expected to hit at $13.81 billion (USD) by 2030.

Which region is expected to hold the highest market share in the Continuous Glucose Monitoring Systems Market?

North America is expected to hold the highest market share in the global market. The region is expected to witness remarkable growth as it houses the major key players in the market.

Which are the top companies in the Continuous Glucose Monitoring Systems Industry?

Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., GlySens Incorporated, Johnson & Johnson, Medtronic plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche Ltd.

What are the market segmentation's and scope of the study?

The global Continuous Glucose Monitoring Systems Market share analysis is based on component, demographics, end user, and region.

How big is the Continuous Glucose Monitoring Systems Market?

Currently (in 2019), the market value stands at USD 1.76 billion and it is anticipated to reach USD 13.81 billion by 2030.